Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin

Protein Expression and Purification

Volumn 8, Issue 2, 1996, Pages 167-174

  Fischer, Bernhard E ^a   Mitterer, Artur ^a   Schlokat, Uwe ^a   Grillberger, Leopold ^a   Reiter, Manfred ^a   Mundt, Wolfgang ^a   Dorner, Friedrich ^a   Eibl, Johann ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CRICETINAE;

EID: 0030250435     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0089     Document Type: Article

References (28)

1. 1. Lundblad, R. L., Fenton, J. W., and Mann, K. G. (1977) "Chemistry and Biology of Thrombin," Ann Arbor Science, Ann Arbor, MI.
2. 2. Jackson, C. M., and Nemerson, Y. (1980) Blood coagulation. Annu. Rev. Biochem. 49, 765-811.
3. 3. Deutsch, E. (1986) "Prothrombin and Other Vitamin K Proteins" (Seeger, W. H., and Walz, D. A., Eds.), Vol. 2, pp. 91-103, CRC Press, Boca Raton, FL.
4. 4. Antonov, V. K. (1993) "Chemistry of Proteolysis," Springer-Verlag, Berlin.
5. 5. Fenton, J. W., Fasco, M. J., Strackrow, A. B., Aronson, D. L., Young, A. M., and Finlayson, J. S. (1977) Human thrombins. J. Biol. Chem. 252, 3587-3598.
6. 6. Miller-Andersson, M., Borg, H., and Andersson, L. O. (1980) Preparation and stability of a highly purified human thrombin standard. Thromb. Res. 20, 109-122.
7. 7. Rosing, J., and Tans, G. (1988) Meizothrombin, a major product of factor Xa-catalysed prothrombin activation. Thromb. Haemostasis 60, 355-360.
8. 8. Owen, G. W., and Jackson, C. M. (1973) Activation of prothrombin with Oxyuranus scutellatus scutellatus (Taipan snake) venom. Thromb. Res. 3, 705-714.
9. 9. Denson, K. W. E. (1969) Coagulant and anticoagulant action of snake venoms. Toxicon 7, 5-11.
10. 10. Markwardt, F. (1958) Die Isolierung und chemische Charakterisierung des Hirudins. Hoppe-Seylers Z. Physiol. Chem. 308, 147-156.
11. 11. Markwardt, F. (1994) The development of hirudin as an antithrombotic drug. Thromb. Res. 74, 1-23.
12. 12. Rydel, T. J., Ravichandran, G. K., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., and Fenton, J. W. (1990) The structure of a complex of recombinant hirudin and alpha-thrombin. Science 249, 277-280.
13. 13. Falkner, F. G., Turecek, P. L., MacGillivray, R. T. A., Bodemer, W., Scheiflinger, F., Kandels, S., Mitterer, A., Kistner, O., Barrett, N., Eibl, J., and Dorner, F. (1992) High level expression of active human prothrombin in a vaccinia virus expression system. Thromb. Haemostasis 68, 119-124.
14. 14. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W. A., and Fuerst, T. R. (1990) New mammalian expression vectors. Nature 348, 91-92.
15. 15. Jang, S. K., and Wimmer, E. (1990) Cap-independent translation of encephalomyocarditis virus RNA: Structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev. 4, 1560-1572.
16. 16. Kaufman, H., and Sharp, P. (1982) Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J. Mol. Biol. 159, 601-621.
17. 17. Urlaub, G., and Chasin, L. A. (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. USA 77, 4216-4220.
18. 18. Graham, F., and van der Eb, L. (1973) A new technique for the assay of infectivity of human adenovirus DNA. Virology 52, 456-487.
19. 19. Fischer, B., Mitterer, A., and Dorner, F. (1995) Structural analysis of recombinant von Willebrand factor. FEBS Lett. 351, 345-348.
20. 20. Fischer, B., Mitterer, A., and Dorner, F. (1995) Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cells. J. Biotechnol. 38, 129-136.
21. 21. Haeberli, A. (1992) "Human Protein Data," VCH, Weinheim/New York.
22. 22. Bradford, M. B. (1976) A radip and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding. Anal. Biochem. 72, 248-254.
23. 23. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227, 680-685.
24. 24. Fischer, B., Mitterer, A., Dorner, F., and Eibl, J. (1996) Comparison of N-glycan pattern od recombinant human coagulation factors II and IX expressed in Chinese hamster ovary (CHO) and African green monkey (Vero) cells. J. Thromb. Thrombolysis 3, 57-62.
25. 25. Fischer, B., Mitterer, A., and Dorner, F. (1996) Comparison of N-glycan pattern of recombinant human coagulation factors II and IX expressed in Chinese hamster ovary and African green monkey cells. Ann. Hematol. 72(Suppl. I), A86.
26. 26. Turecek, P. (1993) Verfahren zur Spaltung von Proteinen. EP 0 565-511.
27. 27. Kisiel, W., and Hanahan, D. J. (1973) The action of factor Xa, thrombin and trypsin on human factor II. Biochim. Biophys. Acta 329, 221-232.
28. 28. Landaburu, R. H., Barnhart, M. I., and Seegers, W. H. (1961) Prothrombin activation with trypsin as enzyme. Am. J. Physiol. 201, 298-302.